In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AGORACOM News Flash

AGORACOM Survey On McCain's Choice For Vice-President:

What Do You Think Of John McCain's Choice for Vice-President?  Bold? Crazay?  Let Us Know Via Our Quick And Anonymous Survey.

Have A Safe And Happy Labor Day Holiday Weekend!

Regards,
George, Paul et al. 

Close
AlphaRx > Message
Generic_profile

Re: NEWS - Zysolin(TM) Improves Survival in Pivotal Animal Studies

Posted by: Tutty on June 27, 2008 12:07PM

In response to: NEWS - Zysolin(TM) Improves... by AGORACOM

AlphaRx is working with regulatory experts to devise a clinical plan for Zysolin(TM) with a view to initiating Phase I human trials in early 2009 - this is what I like. We're on the move and getting the ball rolling. Congrats everyone

Did You Know?

AGORACOM members with a rank of Treasurer or higher can access Time and Sales for TSX and TSX Venture companies

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote